E-CEL UVEC Cells as an Adjunct Cell Therapy for the Arthroscopic Rotator Cuff Repair in Adults
Status:
Recruiting
Trial end date:
2022-07-26
Target enrollment:
Participant gender:
Summary
This is a phase 1b investigator-initiated clinical trial that will evaluate the safety and
feasibility of E-CEL UVEC® cells with the aim of improving outcomes for patients with
full-thickness rotator cuff tears who undergo arthroscopic surgical repair.
Allogeneic E-CEL UVEC cells will be delivered to the tendon repair site and to the muscle
adjacent to the tendon repair site.
Phase:
Phase 1
Details
Lead Sponsor:
Hospital for Special Surgery, New York
Collaborators:
Angiocrine Bioscience Orthopedic Research and Education Foundation